LMR Partners’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,717,472
Closed -$10.7M 1644
2024
Q2
$10.7M Hold
3,717,472
0.09% 196
2024
Q1
$7.99M Hold
3,717,472
0.08% 225
2023
Q4
$5.84M Buy
3,717,472
+419,405
+13% +$493K 0.07% 277
2023
Q3
$4.19M Buy
3,298,067
+18,985
+0.6% +$24.1K 0.05% 279
2023
Q2
$4.07M Buy
3,279,082
+290,258
+10% +$258K 0.05% 274
2023
Q1
$18.2M Buy
2,988,824
+239,399
+9% +$203K 0.28% 92
2022
Q4
$12M Buy
2,749,425
+573,148
+26% +$384K 0.21% 125
2022
Q3
$8.53M Buy
2,176,277
+471,625
+28% +$382K 0.16% 161
2022
Q2
$8.69M Buy
1,704,652
+421,787
+33% +$385K 0.15% 165
2022
Q1
$8.21M Buy
1,282,865
+804,803
+168% +$1.02M 0.1% 221
2021
Q4
$3.83M Buy
+478,062
New +$1.06M 0.04% 300

LMR Partners's CLBTW Position: Q3 2024 in Review

LMR Partners sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q3 2024, closing a stake of 3,717,472 shares — an estimated $10.7M sold.

LMR Partners first reported a position in CLBTW in Q4 2021 and held it in 11 quarters. The position peaked at $18.2M in Q1 2023. 0 funds tracked by Wall St. Rank hold CLBTW as of Q3 2024.

  • LMR Partners reported no remaining Cellebrite DI Ltd. Warrants position as of Q3 2024 after selling out during the quarter.
  • LMR Partners sold 3,717,472 Cellebrite DI Ltd. Warrants shares in Q3 2024, an estimated $10.7M.
  • LMR Partners first reported a position in Cellebrite DI Ltd. Warrants in Q4 2021 and held it in 11 quarters.
  • LMR Partners's Cellebrite DI Ltd. Warrants position peaked at $18.2M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q3 2024.

Based on LMR Partners's 13F filing for Q3 2024, filed 7 Nov 2024.